Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer

The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer

(2020) Kiki M.H. Vangangelt et al.   INTERNATIONAL JOURNAL OF CANCER

Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer

(2020) Aimy Sebastian et al.   Cancers

Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer

(2020) Sunny Z Wu et al.   EMBO JOURNAL

TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up

(2020) Ewan Millar et al.   Cancers

Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome

(2020) Daniele La Forgia et al.   Diagnostics

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

(2019) Sherene Loi et al.   JOURNAL OF CLINICAL ONCOLOGY

Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer

(2019) Oscar G. F. Geessink et al.   CELLULAR ONCOLOGY

Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type

(2019) Giuseppe Dilorenzo et al.   EUROPEAN JOURNAL OF RADIOLOGY

Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer

(2019) Jana Plava et al.   Molecular Cancer

Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy

(2019) J H Park et al.   ANNALS OF ONCOLOGY

CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness

(2018) Shicheng Su et al.   CELL

Involvement of breast cancer associated fibroblasts in tumor development, therapy resistance and evaluation of potential therapeutic strategies

(2018) Maria Rosaria Ruocco et al.   CURRENT MEDICINAL CHEMISTRY

The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients

(2018) K.M.H. Vangangelt et al.   INTERNATIONAL JOURNAL OF CANCER

Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer

(2018) Aurélie S. Cazet et al.   Nature Communications

Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

(2018) Joel Saltz et al.   Cell Reports

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review

(2018) C. J. H. Kramer et al.   BREAST CANCER RESEARCH AND TREATMENT

Turning foes to friends: targeting cancer-associated fibroblasts

(2018) Xueman Chen et al.   NATURE REVIEWS DRUG DISCOVERY

Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing

(2018) Michael Bartoschek et al.   Nature Communications

QuPath: Open source software for digital pathology image analysis

(2017) Peter Bankhead et al.   Scientific Reports

Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen

(2016) Heather M. Brechbuhl et al.   CLINICAL CANCER RESEARCH

High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype

(2016) J. B. Dennison et al.   CLINICAL CANCER RESEARCH

Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis

(2016) Jiayuan Wu et al.   Oncotarget

Prognostic significance of tumour stroma ratio in inflammatory breast cancer

(2015) Candice L Downey et al.   SpringerPlus

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

(2014) R. Salgado et al.   ANNALS OF ONCOLOGY

The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer

(2014) C L Downey et al.   BRITISH JOURNAL OF CANCER

The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer

(2014) F J A Gujam et al.   BRITISH JOURNAL OF CANCER

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

(2013) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)

(2013) T. J. A. Dekker et al.   BREAST CANCER RESEARCH AND TREATMENT

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

The prognostic value of tumour-stroma ratio in triple-negative breast cancer

(2012) A.M. Moorman et al.   EJSO

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53

(2011) E K A Millar et al.   BRITISH JOURNAL OF CANCER

Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

(2010) Esther M. de Kruijf et al.   BREAST CANCER RESEARCH AND TREATMENT

Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel

(2009) Ewan K.A. Millar et al.   JOURNAL OF CLINICAL ONCOLOGY

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

(2009) Pierre Farmer et al.   NATURE MEDICINE